Table 4.
Association between 4gamete defined haplotypes of APC and advanced distal colorectal adenoma risk in non-Hispanic Whites in the Prostate, Lung, Colorectal and Ovarian Screening Trial.
Haplotype | Cases % | Controls% | ORa | 95%CPa | Pb |
---|---|---|---|---|---|
Block 1: rs2304793, rs2229992, rs548710, rs2909786 | |||||
T-C-C-A | 50.9 | 51.3 | 1.00 | Ref | |
C-T-T-A | 2.7 | 1.6 | 3.27 | 1.08–9.88 | 0.04 |
T-C-T-G | 8.0 | 8.3 | 1.00 | 0.56–1.76 | 0.98 |
T-T-T-A | 2.7 | 2.5 | 1.10 | 0.43–2.81 | 0.84 |
T-T-T-G | 35.2 | 35.7 | 1.01 | 0.73–1.41 | 0.95 |
Block 2: rs41115, rs42427, rs459552, rs2229995 | |||||
A-A-A-T | 60.6 | 61.0 | 1.00 | Ref | |
A-A-A-C | 2.2 | 1.9 | 1.37 | 0.45–4.16 | 0.58 |
G-G-A-T | 15.1 | 14.7 | 1.08 | 0.70–1.67 | 0.72 |
G-G-T-T | 21.5 | 21.9 | 0.96 | 0.66–1.38 | 0.81 |
OR odds ratio, adjusted for age, sex, screening center, and race/ethnic groups; CI confidence interval
Global haplotype test (exact test) P =0.97 for all race/ethnic groups and P =0.94 for non-Hispanic Whites only.